{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:49:54Z","timestamp":1761745794713},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,25]]},"DOI":"10.7759\/cureus.34215","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T05:30:40Z","timestamp":1674711040000},"source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the Effects of Caesalpinia crista on Letrozole-Induced Models of Polycystic Ovarian Syndrome"],"prefix":"10.7759","author":[{"given":"Anagha","family":"Shende","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirish","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paresh G","family":"Koli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic DA","year":"2015","unstructured":"Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015, 36:487-525. 10.1210\/er.2015-1018","journal-title":"Endocr Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2004.05.001","article-title":"Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome","volume":"18","author":"Hart R","year":"2004","unstructured":"Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004, 18:671-83. 10.1016\/j.bpobgyn.2004.05.001","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.131162","article-title":"A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India","volume":"18","author":"Joshi B","year":"2014","unstructured":"Joshi B, Mukherjee S, Patil A, Purandare A, Chauhan S, Vaidya R. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocrinol Metab. 2014, 18:317-24. 10.4103\/2230-8210.131162","journal-title":"Indian J Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18203\/2394-6040.ijcmph20175603","article-title":"A cross sectional study of polycystic ovarian syndrome among young women in Bhopal, Central India","volume":"5","author":"Gupta M","year":"2017","unstructured":"Gupta M, Singh D, Toppo M, Priya A, Sethia S, Gupta P. A cross sectional study of polycystic ovarian syndrome among young women in Bhopal, Central India. Int J Community Med Public Health. 2017, 5:95-100. 10.18203\/2394-6040.ijcmph20175603","journal-title":"Int J Community Med Public Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield RL","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016, 37:467-520. 10.1210\/er.2015-1104","journal-title":"Endocr Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale HF","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018, 14:270-84. 10.1038\/nrendo.2018.24","journal-title":"Nat Rev Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi MO","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011, 7:219-31. 10.1038\/nrendo.2010.217","journal-title":"Nat Rev Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00124","article-title":"Poly cystic ovarian syndrome: an updated overview","volume":"7","author":"El Hayek S","year":"2016","unstructured":"El Hayek S, Bitar L, Hamdar LH, Mirza FG, Daoud G. Poly cystic ovarian syndrome: an updated overview. Front Physiol. 2016, 7:124. 10.3389\/fphys.2016.00124","journal-title":"Front Physiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans SM","year":"2013","unstructured":"Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013, 6:1-13. 10.2147\/CLEP.S37559","journal-title":"Clin Epidemiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro RS","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013, 98:4565-92. 10.1210\/jc.2013-2350","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede H","year":"2010","unstructured":"Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010, 8:41. 10.1186\/1741-7015-8-41","journal-title":"BMC Med"},{"key":"ref12","article-title":"Clomiphene for anovulatory infertility","volume":"62","author":"Davidson R","year":"2016","unstructured":"Davidson R, Motan T, Korownyk C. Clomiphene for anovulatory infertility. Can Fam Physician. 2016, 62:492.","journal-title":"Can Fam Physician"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S11304","article-title":"Treatment options for polycystic ovary syndrome","volume":"3","author":"Badawy A","year":"2011","unstructured":"Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Womens Health. 2011, 3:25-35. 10.2147\/IJWH.S11304","journal-title":"Int J Womens Health"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s40738-020-00074-3","article-title":"Staging of the estrous cycle and induction of estrus in experimental rodents: an update","volume":"6","author":"Ajayi AF","year":"2020","unstructured":"Ajayi AF, Akhigbe RE. Staging of the estrous cycle and induction of estrus in experimental rodents: an update. Fertil Res Pract. 2020, 6:5. 10.1186\/s40738-020-00074-3","journal-title":"Fertil Res Pract"},{"key":"ref15","article-title":"Bhavaprakasa nighantu","author":"Chunekar KC","year":"2010","unstructured":"Chunekar KC. Bhavaprakasa nighantu. Sri bhavamisra. Pandey GS (ed): Chaukhambha Bharati Academy, Varanasi, Varanasi, India; 2010. 126-7."},{"key":"ref16","article-title":"Traditional uses, medicinal and phytopharmacological properties of Caesalpinia crista Linn - an overview","volume":"1","author":"Suryawanshi H","year":"2011","unstructured":"Suryawanshi H, Patel M. Traditional uses, medicinal and phytopharmacological properties of Caesalpinia crista Linn - an overview. Int J Res Pharm Chem. 2011, 1:1179-83.","journal-title":"Int J Res Pharm Chem"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.53517\/CMDR.2581-5008.312019191","article-title":"Caesalpinia crista L.: a review on traditional uses, phytochemistry and pharmacological properties","volume":"3","author":"Upadhyay P","year":"2019","unstructured":"Upadhyay P, Joshi BC, Sundriyal A, Uniyal S. Caesalpinia crista L.: a review on traditional uses, phytochemistry and pharmacological properties. Curr Med Drug Res. 2019, 3:1-6.","journal-title":"Curr Med Drug Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.05.009","article-title":"Introduction: determinants of polycystic ovary\u00a0syndrome","volume":"106","author":"Azziz R","year":"2016","unstructured":"Azziz R. Introduction: determinants of polycystic ovary\u00a0syndrome. Fertil Steril. 2016, 106:4-5. 10.1016\/j.fertnstert.2016.05.009","journal-title":"Fertil Steril"},{"key":"ref19","article-title":"Management of vandhyatwa with anovulatory cycles (Artava dosha) by Ayurvedic medicines","volume":"3","author":"Subbalakshmi B","year":"2014","unstructured":"Subbalakshmi B. Management of vandhyatwa with anovulatory cycles (Artava dosha) by Ayurvedic medicines. Ayurpharm - Int J Ayurveda Allied Sci. 2014, 3:177-85.","journal-title":"Ayurpharm - Int J Ayurveda Allied Sci"},{"key":"ref20","article-title":"Ovulation induction by ayurvedic medicines: a review","volume":"3","author":"Rajaram TP","year":"2014","unstructured":"Rajaram TP, Ambadas SR, Sudhir CS. Ovulation induction by ayurvedic medicines: a review. ANJRAS. 2014, 3:1-9.","journal-title":"ANJRAS"},{"key":"ref21","article-title":"Phytochemical investigation of Caesalpinia crista seed extract for their therapeutic potential","volume":"6","author":"Gill NS","year":"2012","unstructured":"Gill NS, Kaur R, Arora R, Bali M. Phytochemical investigation of Caesalpinia crista seed extract for their therapeutic potential. Res J Medicinal Plant. 2012, 6:100-7.","journal-title":"Res J Medicinal Plant"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.22270\/JDDT.V8I5.1880","article-title":"Antiplasmodial activity of Caesalpinia crista seed extracts","volume":"8","author":"Reddy MS","year":"2018","unstructured":"Reddy MS, Kuber BR. Antiplasmodial activity of Caesalpinia crista seed extracts. JDDT. 2018, 8:354-7. 10.22270\/JDDT.V8I5.1880","journal-title":"JDDT"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2013.05.004","article-title":"Animal models of the polycystic ovary syndrome phenotype","volume":"78","author":"Padmanabhan V","year":"2013","unstructured":"Padmanabhan V, Veiga-Lopez A. Animal models of the polycystic ovary syndrome phenotype. Steroids. 2013, 78:734-40. 10.1016\/j.steroids.2013.05.004","journal-title":"Steroids"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/1757-2215-5-15","article-title":"Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats","volume":"5","author":"Wang F","year":"2012","unstructured":"Wang F, Yu B, Yang W, Liu J, Lu J, Xia X. Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats. J Ovarian Res. 2012, 5:15. 10.1186\/1757-2215-5-15","journal-title":"J Ovarian Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.04.006","article-title":"Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk","volume":"98","author":"Shi D","year":"2012","unstructured":"Shi D, Vine DF. Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk. Fertil Steril. 2012, 98:185-93. 10.1016\/j.fertnstert.2012.04.006","journal-title":"Fertil Steril"},{"key":"ref26","unstructured":"CLOMID\u00ae. (2023). https.\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/016131s026lbl.pdf."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1530\/REP-15-0352","article-title":"Letrozole vs estradiol valerate induced PCOS in rats: glycemic, oxidative and inflammatory status assessment","volume":"151","author":"D\u0103neas\u0103 A","year":"2016","unstructured":"D\u0103neas\u0103 A, Cucola\u015f C, Lenghel LM, Olteanu D, Or\u0103san R, Filip GA. Letrozole vs estradiol valerate induced PCOS in rats: glycemic, oxidative and inflammatory status assessment. Reproduction. 2016, 151:401-9. 10.1530\/REP-15-0352","journal-title":"Reproduction"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2003.10.005","article-title":"Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease","volume":"35","author":"Kafali H","year":"2004","unstructured":"Kafali H, Iriadam M, Ozardali I, Demir N. Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch Med Res. 2004, 35:103-8. 10.1016\/j.arcmed.2003.10.005","journal-title":"Arch Med Res"},{"key":"ref29","article-title":"A review towards PCOS in Ayurveda","volume":"3","author":"Shama M","year":"2017","unstructured":"Shama M. A review towards PCOS in Ayurveda. World J Pharm Med Res. 2017, 3:372-4.","journal-title":"World J Pharm Med Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.7897\/2277-4343.074123","article-title":"Ayurvedic approaches to polycystic ovary syndrome (PCOS): a review","volume":"7","author":"Purnima R","year":"2016","unstructured":"Purnima R, Pradeep P, Balendra S, Nalini D. Ayurvedic approaches to polycystic ovary syndrome (PCOS): a review. Int J Res Ayurveda Pharm. 2016, 7:4-7. 10.7897\/2277-4343.074123","journal-title":"Int J Res Ayurveda Pharm"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/128337-evaluation-of-the-effects-of-caesalpinia-crista-on-letrozole-induced-models-of-polycystic-ovarian-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:05Z","timestamp":1707508685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/128337-evaluation-of-the-effects-of-caesalpinia-crista-on-letrozole-induced-models-of-polycystic-ovarian-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.34215","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,25]]}}}